ADJUTEC PHARMA AS: årsregnskap 2020 vs 2019
Fresh owner capital
approved 2021-04-13; registry 2021-05-11; journal 2021 225888
Summary
What changed
Comparing Årsregnskap 2020 with 2019 for ADJUTEC PHARMA AS. Revenue 0 NOK → 612 NOK. Equity 24.4k NOK → 1.28m NOK.
On the constructive side: revenue rose; equity strengthened; cash rose.
Net constructive year on the published lines.
At a glance
Scorecard
Revenue
0 NOK
612 NOK
—
Operating result
n/m
-746.8k NOK
—
Net result
n/m
-747.3k NOK
—
Equity
24.4k NOK
1.28m NOK
+5127.9%
Cash
30.0k NOK
1.52m NOK
+4965.3%
Total assets
30.0k NOK
1.54m NOK
+5035.0%
What improved
-
↑
Revenue rose
Operating income / revenue moved from 0 NOK to 612 NOK. Calculated
-
↑
Equity strengthened
Book equity 24.4k NOK → 1.28m NOK (equity ratio 81.4% → 82.9%). Calculated
-
↑
Cash rose
Bank deposits 30.0k NOK → 1.52m NOK (+4965.3% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 24.4k NOK → 2.02m NOK (+2.00m NOK). Reported fact